Overview
- Annals editor-in-chief Christine Laine said there is no evidence of scientific misconduct or serious errors that would warrant retracting the paper.
- HHS Secretary Robert F. Kennedy Jr. had accused the study of design flaws and data manipulation in an opinion piece calling for immediate withdrawal.
- Lead authors detailed additional analyses, including shifted follow-up periods, that produced consistent results and explained why an unvaccinated control group was impractical.
- The researchers noted Danish and EU privacy laws prohibit public release of individual-level health data despite independent requests for transparency.
- Multiple external experts affirmed that the observational limits acknowledged by the authors do not undermine the conclusion that aluminum adjuvants pose no increased risk.